Evidence map›Paper›PMID 35159154›Full record

ArticleCells2022

Down-Regulation of the Longevity-Associated Protein SIRT1 in Peripheral Blood Mononuclear Cells of Treated HIV Patients.

Aleksandra Gruevska, Ángela B Moragrega, María J Galindo, Juan V Esplugues, Ana Blas-García, Nadezda Apostolova

Open access · goldAbstract read
In one paragraph

Article in Cells, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. HIV-1 replication and latency are balanced by mTOR-driven cell metabolism.Frontiers in cellular and infection microbiology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Aleksandra GruevskaDepartamento de Farmacología, Universidad de Valencia, 46010 Valencia, Spain.ORCID 0000-0003-4411-829X
Ángela B MoragregaDepartamento de Farmacología, Universidad de Valencia, 46010 Valencia, Spain.ORCID 0000-0003-1568-2342
María J GalindoUnidad de Enfermedades Infecciosas-Medicina Interna, Hospital Clínico Universitario de Valencia, 46010 Valencia, Spain.
Juan V EspluguesDepartamento de Farmacología, Universidad de Valencia, 46010 Valencia, Spain.
Ana Blas-GarcíaFundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO), 46020 Valencia, Spain.ORCID 0000-0001-7870-1470
Nadezda ApostolovaDepartamento de Farmacología, Universidad de Valencia, 46010 Valencia, Spain.ORCID 0000-0002-4487-2471
Universitat de València · ESHospital Clínico Universitario de Valencia · ES

Funding

Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas EHD19PI03Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana UGP-19-033Generalitat Valenciana PROMETEO/2018/141Ministerio de Ciencia, Innovación y Universidades CIBER CB06/04/0071Ministerio de Ciencia, Innovación y Universidades RTI2018-096748-B-100Ministerio de Ciencia, Innovación y Universidades RTI2018-94436-B-100
6 · The paper itself

Abstract

The activity of sirtuin 1 (SIRT1), a class III histone deacetylase with a critical role in several biological functions, decreases with age and its deficiency is associated with many inflammatory and age-related diseases. It also regulates the chronic immune activation and viral latency during an HIV infection. The life-span and particularly the health span of HIV patients are substantially shortened; however, the participation of SIRT1 in these effects is not clear. We performed a prospective cross-sectional monocentric study that included 70 HIV-infected patients and 43 BMI-, age- and sex-matched uninfected individuals. We found that in the PBMCs of the HIV patients,

Indexed as

HIV InfectionsSirtuinsBiomarkersCD8-Positive T-LymphocytesCross-Sectional StudiesDown-RegulationHumansLeukocytes, MononuclearLongevityProspective StudiesSirtuin 1BiomarkersSIRT1 protein, humanSirtuin 1Sirtuinsagingantiretroviral drugsHIVinflammationPBMCSIRT1

Identifiers

PMID35159154
PMCPMC8834054
OpenAlexW4205625853

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.